Maria Gazouli

85PUBLICATIONS
257CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PeriodonticsPredictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (85)

|Jul 28, 2026
Evaluation of Longitudinal CD40 and CD40L Changes During Adjuvant Breast Cancer Therapy and Their Association with Left Ventricular Dysfunction.

|Jun 25, 2026
3D-Bioprinted Multifunctional Nanocomposite Scaffolds for Alveolar Bone-Periodontal Ligament-Root Cementum Regeneration: A Narrative Review.

|Apr 27, 2026
Predictors of Response to Induction Therapy with Ustekinumab in Patients with Ulcerative Colitis: Results from a National Study in Greece.

|Feb 27, 2026
Correction: Anastasiou et al. MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients. Pharmaceuticals 2025, 18, 1908.

Maria Anastasiou, Evangelos Oikonomou, Panagiotis Theofilis

|Feb 27, 2026
Circulating ERVFRD-1 and MFSD2A Are Associated with Immunotherapy Response in Metastatic Clear Cell Renal Cell Carcinoma.

Hector Katifelis, Styliani-Evangelia Zerva, Aristotelis Bamias

|Jan 28, 2026
Temporal Expression of NLRP3 Inflammasome Components in Patients with Acute Coronary Syndrome.

Paraskevi Papanikolaou, Andreas Aggelopoulos, Alexios S Antonopoulos

Pageof 15

Frequent Collaborators

13 joint publications

Hector Katifelis

10 joint publications

Federico Canzian

9 joint publications

Nikolas Dovrolis

9 joint publications

Manuel Gentiluomo